标题
Novel Anti-fibrotic Therapies
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-05-31
DOI
10.3389/fphar.2017.00318
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice
- (2017) Giuseppe Derosa et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pioglitazone and bladder cancer: FDA's assessment
- (2017) Christian Hampp et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- GW0742, a High Affinity PPAR-β/δ Agonist Reduces Lung Inflammation Induced by Bleomycin Instillation in Mice
- (2017) M. Galuppo et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
- (2016) Nadira Ruzehaji et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of relaxin on cardiac fibrosis, apoptosis, and tachyarrhythmia in rats with myocardial infarction
- (2016) Deguo Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Anti-fibrotic actions of relaxin
- (2016) C S Samuel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench
- (2016) Wei-Ting Chang et al. Cardiovascular Diabetology
- BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery
- (2016) David Merino et al. CARDIOVASCULAR RESEARCH
- MiR-22 may Suppress Fibrogenesis by Targeting TGFβR I in Cardiac Fibroblasts
- (2016) Yuan Hong et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- BMP-7 attenuated silica-induced pulmonary fibrosis through modulation of the balance between TGF-β/Smad and BMP-7/Smad signaling pathway
- (2016) Di Liang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease
- (2016) S. G. Royce et al. CLINICAL SCIENCE
- Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice
- (2016) J. Zhang et al. CLINICAL SCIENCE
- Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering Medications
- (2016) Byron J. Hoogwerf et al. DIABETES CARE
- PPAR-γ is involved in the protective effect of 2,3,4',5-tetrahydroxystilbene-2-O-beta-D-glucoside against cardiac fibrosis in pressure-overloaded rats
- (2016) Yi Peng et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PPARα agonist, fenofibrate, ameliorates age-related renal injury
- (2016) Eun Nim Kim et al. EXPERIMENTAL GERONTOLOGY
- Hepatic injury associated with Trypanosoma cruzi infection is attenuated by treatment with 15-deoxy-Δ 12,14 prostaglandin J 2
- (2016) Federico Nicolás Penas et al. EXPERIMENTAL PARASITOLOGY
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis
- (2016) Silvia Speca et al. INFLAMMATORY BOWEL DISEASES
- Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding
- (2016) Senem Aykul et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- OS 05-08 ELMISARTAN IMPROVES CARDIAC FIBROSIS IN DIABETES THROUGH PPARδ/STAT3 PATHWAY—FROM BEDSIDE TO BENCH
- (2016) Chang Wei-Ting et al. JOURNAL OF HYPERTENSION
- Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-γ)
- (2016) Miao Chen et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Attenuation of liver fibrosis by herbal compound 861 via upregulation of BMP-7/Smad signaling in the bile duct ligation model rat
- (2016) FEI HOU et al. Molecular Medicine Reports
- Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis
- (2016) Bo Wang et al. MOLECULAR THERAPY
- Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease
- (2016) Robert G. Gourdie et al. NATURE REVIEWS DRUG DISCOVERY
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus
- (2016) Abd A. Tahrani et al. Nature Reviews Endocrinology
- Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension
- (2016) Arnica Behringer et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- BMP-7 Attenuates TGF-β1-Induced Fibronectin Secretion and Apoptosis of NRK-52E Cells by the Suppression of miRNA-21
- (2016) Zhong Yu et al. ONCOLOGY RESEARCH
- Effects of Peroxisome Proliferator-Activated Receptor-δ Agonist on Cardiac Healing after Myocardial Infarction
- (2016) Jeong Rang Park et al. PLoS One
- Antifibrotic Actions of Serelaxin – New Roles for an Old Player
- (2016) Chrishan S. Samuel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis
- (2016) Rayne R. Lim et al. Scientific Reports
- The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways
- (2016) Carmen del Río et al. Scientific Reports
- Serelaxin Elicits Bronchodilation and Enhances β-Adrenoceptor-Mediated Airway Relaxation
- (2016) Maggie Lam et al. Frontiers in Pharmacology
- Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
- (2016) Hans-Theo Schon et al. Frontiers in Pharmacology
- Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells
- (2016) Soo-Mi Kweon et al. PLoS One
- Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis
- (2016) Swayam Prakash Srivastava et al. Scientific Reports
- The role of miR-29 in pulmonary fibrosis
- (2015) Leah Cushing et al. Biochemistry and Cell Biology
- Radix puerariae extracts ameliorate paraquat-induced pulmonary fibrosis by attenuating follistatin-like 1 and nuclear factor erythroid 2p45-related factor-2 signalling pathways through downregulation of miRNA-21 expression
- (2015) Ming-wei Liu et al. BMC Complementary and Alternative Medicine
- Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Through NF-κB/Brg1 and TGF-ß1 Pathways Attenuates Cardiac Remodeling in Pressure-Overloaded Rat Hearts
- (2015) Han-Ping Qi et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Peroxisome Proliferator-Activated Receptor Gamma Negatively Regulates the Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Toward Myofibroblasts in Liver Fibrogenesis
- (2015) Shuangshuang Jia et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy
- (2015) Brooke M. Huuskes et al. FASEB JOURNAL
- Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease
- (2015) Sahar Mohamed El-Haggar et al. Hepatology International
- Hyaluronan Regulates Bone Morphogenetic Protein-7-dependent Prevention and Reversal of Myofibroblast Phenotype
- (2015) Adam C. Midgley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- microRNA-29b Mediates the Antifibrotic Effect of Tanshinone IIA in Postinfarct Cardiac Remodeling
- (2015) Fan Yang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21
- (2015) Xue Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation
- (2015) Fujun Yu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Relaxin-2 Does Not Ameliorate Nephropathy in an Experimental Model of Type-1 Diabetes
- (2015) Thomas Bernd Dschietzig et al. KIDNEY & BLOOD PRESSURE RESEARCH
- A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model
- (2015) Monica Mangoni et al. LUNG CANCER
- Unknown
- (2015) Giuseppina Nicolini et al. MOLECULAR MEDICINE
- Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease
- (2015) Simon G. Royce et al. Stem Cell Research
- Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway
- (2015) Xi Zhou et al. Drug Design Development and Therapy
- Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
- (2015) Ling Chen et al. Oncotarget
- Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney
- (2014) Marijn M. Speeckaert et al. AGEING RESEARCH REVIEWS
- Rosiglitazone Attenuates Atrial Structural Remodeling and Atrial Fibrillation Promotion in Alloxan-Induced Diabetic Rabbits
- (2014) Tong Liu et al. Cardiovascular Therapeutics
- Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease
- (2014) S. G. Royce et al. CLINICAL AND EXPERIMENTAL ALLERGY
- The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice
- (2014) Michal Pawlak et al. HEPATOLOGY
- Serelaxin Is a More Efficacious Antifibrotic Than Enalapril in an Experimental Model of Heart Disease
- (2014) Chrishan S. Samuel et al. HYPERTENSION
- Relaxin Activates Peroxisome Proliferator-activated Receptor γ (PPARγ) through a Pathway Involving PPARγ Coactivator 1α (PGC1α)
- (2014) Sudhir Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tet3-Mediated Hydroxymethylation of Epigenetically Silenced Genes Contributes to Bone Morphogenic Protein 7-Induced Reversal of Kidney Fibrosis
- (2014) B. Tampe et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis
- (2014) Bryna S. Man Chow et al. KIDNEY INTERNATIONAL
- The Antifibrotic Effects and Mechanisms of MicroRNA-26a Action in Idiopathic Pulmonary Fibrosis
- (2014) Haihai Liang et al. MOLECULAR THERAPY
- MicroRNAs in IgA nephropathy
- (2014) Cheuk-Chun Szeto et al. Nature Reviews Nephrology
- Protective Effects of Relaxin against Cisplatin-Induced Nephrotoxicity in Rats
- (2014) Takuya Yoshida et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats
- (2014) Pitchai Balakumar et al. PHARMACOLOGICAL RESEARCH
- Therapeutic Effects of Fenofibrate on Diabetic Peripheral Neuropathy by Improving Endothelial and Neural Survival in db/db Mice
- (2014) Ye Rim Cho et al. PLoS One
- New Insights into the PPARγAgonists for the Treatment of Diabetic Nephropathy
- (2014) Zhanjun Jia et al. PPAR Research
- The Antifibrosis Effects of Peroxisome Proliferator-Activated Receptorδon Rat Corneal Wound Healing after Excimer Laser Keratectomy
- (2014) Yun Gu et al. PPAR Research
- N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition
- (2014) Takako Nagai et al. Biomed Research International
- The Peroxisome Proliferator–Activated Receptor β/δ Agonist GW0742 has Direct Protective Effects on Right Heart Hypertrophy
- (2014) Baktybek Kojonazarov et al. Pulmonary Circulation
- MicroRNA-326 Regulates Profibrotic Functions of Transforming Growth Factor-β in Pulmonary Fibrosis
- (2013) Sudipta Das et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies
- (2013) Joel Rosenbloom ANNALS OF INTERNAL MEDICINE
- A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses
- (2013) Jun Wei et al. ANNALS OF THE RHEUMATIC DISEASES
- Origins and functions of liver myofibroblasts
- (2013) Sara Lemoinne et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Relaxin Suppresses Atrial Fibrillation by Reversing Fibrosis and Myocyte Hypertrophy and Increasing Conduction Velocity and Sodium Current in Spontaneously Hypertensive Rat Hearts
- (2013) Ashish Parikh et al. CIRCULATION RESEARCH
- Fenofibrate A peroxisome proliferator activated receptor-α agonist treatment ameliorates Concanavalin A-induced hepatitis in rats
- (2013) Doaa I. Mohamed et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Antifibrotic effect of atorvastatin on paraquat-induced pulmonary fibrosis: Role of PPARγ receptors
- (2013) Hassan Malekinejad et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension
- (2013) Siu-Lung Chan et al. FASEB JOURNAL
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertensionin vivo
- (2013) Jonathan A. Fallowfield et al. HEPATOLOGY
- Macrophage plasticity and polarization in liver homeostasis and pathology
- (2013) Antonio Sica et al. HEPATOLOGY
- Hepatic molecular effects of rosiglitazone in human non-alcoholic steatohepatitis suggest long-term pro-inflammatory damage
- (2013) Maud Lemoine et al. HEPATOLOGY RESEARCH
- The PPARβ/δ Agonist GW501516 Attenuates Peritonitis in Peritoneal Fibrosis via Inhibition of TAK1–NFκB Pathway in Rats
- (2013) Xuesong Su et al. INFLAMMATION
- MicroRNA-214 Antagonism Protects against Renal Fibrosis
- (2013) L. Denby et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice
- (2013) Zhen-Zhou Zhang et al. Journal of Translational Medicine
- Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice
- (2013) Yue-Min Nan et al. Lipids in Health and Disease
- Relaxin decreases the severity of established hepatic fibrosis in mice
- (2013) Robert G. Bennett et al. LIVER INTERNATIONAL
- Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis
- (2013) Virender Kumar et al. PHARMACEUTICAL RESEARCH
- Relaxin Family Peptides and Their Receptors
- (2013) R. A. D. Bathgate et al. PHYSIOLOGICAL REVIEWS
- Peroxisome Proliferator-Activated Receptor δ Agonist, HPP593, Prevents Renal Necrosis under Chronic Ischemia
- (2013) Larisa V. Fedorova et al. PLoS One
- Bone Marrow Progenitor Cell Therapy-Mediated Paracrine Regulation of Cardiac miRNA-155 Modulates Fibrotic Response in Diabetic Hearts
- (2013) Raj Kishore et al. PLoS One
- The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes
- (2013) Su Wong et al. PROTEIN AND PEPTIDE LETTERS
- Therapy for Fibrotic Diseases: Nearing the Starting Line
- (2013) S. L. Friedman et al. Science Translational Medicine
- Bone morphogenetic protein-7 inhibits silica-induced pulmonary fibrosis in rats
- (2013) Gengxia Yang et al. TOXICOLOGY LETTERS
- Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis inSchistosoma japonicum-infected miceviatransforming growth factor-β/Smad signaling
- (2013) Bo-Lin Chen WORLD JOURNAL OF GASTROENTEROLOGY
- Cardiac and Renal Protective Effects of Irbesartan via Peroxisome Proliferator‐Activated Receptorγ–Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1a Receptor Blockade in Mouse Model of Salt‐Sensitive Hypertension
- (2013) Hiroshi Kusunoki et al. Journal of the American Heart Association
- Bone Morphogenetic Protein–Inducer Tilorone Identified by High-Throughput Screening Is AntifibroticIn Vivo
- (2012) Outi Leppäranta et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
- (2012) Estrella Garcia Gonzalez et al. ANNALS OF THE RHEUMATIC DISEASES
- Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation
- (2012) John P. Iredale et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Strategies for anti-fibrotic therapies
- (2012) Joel Rosenbloom et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair
- (2012) Maciej Lech et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-β1 Pathway
- (2012) Zhenwei Pan et al. CIRCULATION
- Role of the TGF-β/BMP-7/Smad pathways in renal diseases
- (2012) Xiao-Ming Meng et al. CLINICAL SCIENCE
- Effects of the dual PPAR-α/γ agonist aleglitazar on glycaemic control and organ protection in the Zucker diabetic fatty rat
- (2012) A. Bénardeau et al. DIABETES OBESITY & METABOLISM
- Up-Regulating Relaxin Expression by G-Quadruplex Interactive Ligand to Achieve Antifibrotic Action
- (2012) Hui-Ping Gu et al. ENDOCRINOLOGY
- Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats
- (2012) M. Samah et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Different Roles of PPAR-γ Activity on Physiological and Pathological Alteration After Myocardial Ischemia
- (2012) Ayako Nagashima et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats
- (2012) Aina Rodríguez-Vilarrupla et al. JOURNAL OF HEPATOLOGY
- miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis
- (2012) Christoph Roderburg et al. JOURNAL OF HEPATOLOGY
- Oral Administration of Recombinant Adeno-associated Virus-mediated Bone Morphogenetic Protein-7 Suppresses CCl4-induced Hepatic Fibrosis in Mice
- (2012) Zhi-Ming Hao et al. MOLECULAR THERAPY
- Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis
- (2012) Hikaru Sugimoto et al. NATURE MEDICINE
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
- (2012) Alison J. Kriegel et al. PHYSIOLOGICAL GENOMICS
- Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS
- (2012) Bryna Suet Man Chow et al. PLoS One
- Protection from liver fibrosis by a peroxisome proliferator-activated receptor agonist
- (2012) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation
- (2012) Radina Kostadinova et al. Cell and Bioscience
- Relaxin and Castration in Male Mice Protect from, but Testosterone Exacerbates, Age-Related Cardiac and Renal Fibrosis, Whereas Estrogens Are an Independent Determinant of Organ Size
- (2011) Tim D. Hewitson et al. ENDOCRINOLOGY
- Relaxin causes selective outward remodeling of brain parenchymal arterioles via activation of peroxisome proliferator-activated receptor-γ
- (2011) Siu-Lung Chan et al. FASEB JOURNAL
- Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
- (2011) Dawn M. Torres et al. HEPATOLOGY
- Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect
- (2011) Melissa D. Yang et al. HEPATOLOGY
- Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes
- (2011) Gaurang Patel et al. JOURNAL OF DRUG TARGETING
- The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysis
- (2011) Suzanne E. Mahady et al. JOURNAL OF HEPATOLOGY
- Transforming growth factor-β inhibits myocardial PPARγ expression in pressure overload-induced cardiac fibrosis and remodeling in mice
- (2011) Kaizheng Gong et al. JOURNAL OF HYPERTENSION
- Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis
- (2011) Yuki Tanaka et al. KIDNEY INTERNATIONAL
- The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats
- (2011) Peter Boor et al. KIDNEY INTERNATIONAL
- Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma
- (2011) Yasuhiro Maejima et al. LABORATORY INVESTIGATION
- Relaxin remodels fibrotic healing following myocardial infarction
- (2011) Chrishan S Samuel et al. LABORATORY INVESTIGATION
- Relaxin ameliorates salt-sensitive hypertension and renal fibrosis
- (2011) T. Yoshida et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
- (2011) Alexandra Rogue et al. PLoS One
- Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction
- (2011) Monika Kwiecinski et al. PLoS One
- PPARα agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity
- (2010) Xiaoyang Hou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol
- (2010) Paras K Mishra et al. Cardiovascular Diabetology
- Antifibrotic Properties of Relaxin:In VivoMechanism of Action in Experimental Renal Tubulointerstitial Fibrosis
- (2010) Tim D. Hewitson et al. ENDOCRINOLOGY
- Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy
- (2010) Lingyun Li et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Fibrocytes in health and disease
- (2010) Erica L. Herzog et al. EXPERIMENTAL HEMATOLOGY
- MicroRNAs and the regulation of fibrosis
- (2010) Xiaoying Jiang et al. FEBS Journal
- BMP-7 as antagonist of organ fibrosis
- (2010) Ralf Weiskirchen Frontiers in Bioscience-Landmark
- Effectiveness of the PPARγ agonist, GW570, in liver fibrosis
- (2010) Liu Yang et al. INFLAMMATION RESEARCH
- Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome
- (2010) Mari Tanaka et al. JOURNAL OF CLINICAL INVESTIGATION
- Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes
- (2010) Fredrick L. Dunn et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Prevention of Bleomycin-Induced Pulmonary Fibrosis by a Novel Antifibrotic Peptide with Relaxin-Like Activity
- (2010) A. Pini et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
- (2009) Minghua Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- Improving insulin sensitivity via activation of PPAR-γ increases telomerase activity in the heart of OLETF rats
- (2009) Naoki Makino et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Relaxin Reduces Fibrosis in Models of Progressive and Established Hepatic Fibrosis
- (2009) Robert G. Bennett et al. Annals of the New York Academy of Sciences
- Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: A randomized, double-blind, placebo-controlled trial
- (2009) Dinesh Khanna et al. ARTHRITIS AND RHEUMATISM
- Peroxisome proliferator-activated receptor-γ activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor
- (2009) Sang-Hyun Ihm et al. BASIC RESEARCH IN CARDIOLOGY
- Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat
- (2009) Fabien Forcheron et al. Cardiovascular Diabetology
- Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines
- (2009) Hongli Shan et al. CARDIOVASCULAR RESEARCH
- MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue
- (2009) Sashwati Roy et al. CARDIOVASCULAR RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Relaxin Reverses Airway Remodeling and Airway Dysfunction in Allergic Airways Disease
- (2009) Simon G. Royce et al. ENDOCRINOLOGY
- miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis
- (2009) Can-Jie Guo et al. JOURNAL OF HEPATOLOGY
- Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
- (2009) Luciano De Petrocellis et al. Journal of Neuroimmune Pharmacology
- Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
- (2009) John R Teerlink et al. LANCET
- Relaxin signaling activates peroxisome proliferator-activated receptor gamma
- (2009) Sudhir Singh et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
- (2009) Mitsuo Kato et al. NATURE CELL BIOLOGY
- Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions
- (2009) Nicolas Pottier et al. PLoS One
- Relaxin and its role in the development and treatment of fibrosis
- (2009) Robert G. Bennett Translational Research
- miR-133 and miR-30 Regulate Connective Tissue Growth Factor
- (2008) Rudy F. Duisters et al. CIRCULATION RESEARCH
- Differential Roles of Cardiomyocyte and Macrophage Peroxisome Proliferator-Activated Receptor in Cardiac Fibrosis
- (2008) E. Caglayan et al. DIABETES
- Additive Inhibitory Effect of Experimentally Induced Hepatic Cirrhosis by Agonists of Peroxisome Proliferator Activator Receptor γ and Retinoic Acid Receptor
- (2008) Rafael Bruck et al. DIGESTIVE DISEASES AND SCIENCES
- Relaxin Ameliorates Fibrosis in Experimental Diabetic Cardiomyopathy
- (2008) Chrishan S. Samuel et al. ENDOCRINOLOGY
- MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy
- (2008) Qiang Wang et al. FASEB JOURNAL
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy
- (2008) Massimo Bonacchi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- BMP-7 protects mesangial cells from injury by polymeric IgA
- (2008) Wai Long Chan et al. KIDNEY INTERNATIONAL
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
- A soluble activin Type IIA receptor induces bone formation and improves skeletal integrity
- (2008) R. S. Pearsall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
- (2008) E. van Rooij et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Ligand, Suppresses Bleomycin-Induced Acute Lung Injury and Fibrosis
- (2008) Yasuhiro Aoki et al. RESPIRATION
- PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
- (2008) Stephan Barrientos et al. WOUND REPAIR AND REGENERATION
- PPAR-γ agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis
- (2007) Jami E. Milam et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Gremlin-mediated Decrease in Bone Morphogenetic Protein Signaling Promotes Pulmonary Fibrosis
- (2007) Marjukka Myllärniemi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors
- (2007) S E O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- Endogenous Relaxin Does Not Affect Chronic Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
- (2007) Qi Xu et al. ENDOCRINOLOGY
- Beneficial Effects of Pioglitazone on Hypertensive Cardiovascular Injury Are Enhanced by Combination With Candesartan
- (2007) Taishi Nakamura et al. HYPERTENSION
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
- Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis
- (2007) R.A.D. Bathgate et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started